Research
October 22, 2025
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
June 28, 2024
June 26, 2024
June 19, 2024
June 10, 2024
May 31, 2024
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community